If BLA were to be accepted and the FDA issued PDUFA date, isn’t this also consider as regulatory milestones? If that is the case, should CYDY also get an upfront payment from Vyera or until Virologix approval?

“In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone payments of up to $87.5 million”.